Ireland
--:--IST
Latest
Clinical Trials in Belgium / NCT07636343
Recruiting Not applicable

Eccentric Muscle Training in Cardiac Rehabilitation

NCT07636343 · tracked via the Priya Life Science Belgium tracker
Phase
Not applicable
Started
2023-01-20
Last updated
2026-06-09

Condition(s) studied

Strength Training EffectsHFrEF - Heart Failure With Reduced Ejection Fraction

Investigational drug(s) / intervention(s)

eccentric bike trainingeccentric overload trainingaerobic treadmill trainingaerobic bike trainingtraditional dynamic strength training

eccentric bike training: progressive following protocol, 10min

eccentric overload training: dynamic strength training + eccentric overload, progressive over time, 3sets\*10reps (15-20min)

aerobic treadmill training: aerobic training, progressive over time, 10 min

aerobic bike training: aerobic training, progressive following protocol, 10 min

traditional dynamic strength training: dynamic strength training, progression over time, 15-20 min

Study summary

The goal of this interventional study is to assess the training effects in a training schedule in which eccentric overload training and eccentric cycle training are used.

Researchers will compare a training program of eccentric overload training and eccentric cycling training with a traditional training program of strength and cardio training in people with heart failure with reduced ejection fraction.

This study will be delivered in a cardiac rehabilitation setting.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * HFrEF patients with ejection fraction \<40% * Exercise intolerance (\<85% of predicted VO2 peak) * clinically stable for \> 6 weeks, optimal medical treatment for \> 6 weeks Exclusion Criteria: * Contra indications for cardiac exercise rehabilitation as per consensus guidelines and recommendations * Musculoskeletal disorders that hamper (progression in) strength training * Non-stabilized acute coronary syndrome * Current acute heart failure (decompensation) * Patient having sustained a recent (\<3 months) procedure that could act as a confounder to increase VO2peak (i.e., coronary artery bypass graft surgery, percutaneous coronary intervention, cardiac resynchronization therapy, valve surgery or reparation)

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
UHAntwerp Edegem Belgium Recruiting

More University Hospital, Antwerp trials in Belgium

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07636343 on ClinicalTrials.gov ↗ ← All trials in Belgium